Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Completed

Phase 3 Results N/A

Eligibility Criteria

Inclusion Criteria

- 18 to 75 years of age, inclusive
- Clinical diagnosis of PBA (pseudobulbar affect)
- If female, must not be pregnant or breast feeding

Exclusion Criteria

- Sensitivity to quinidine or any opiate drugs
- Current or prior history of major psychiatric disturbance
- Currently participated in a trial within the past 30 days